Three- versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) project

Publication | Open Access

DOI Full Paper Access

Citations

References

2019

Year

John Souglakos, Ioannis Boukovinas, Stylianos Kakolyris, S. Xynogalos, Nikolaos Ziras, A. Athanasiadis, Nikolaos Androulakis, Athina Christopoulou, Michael Vaslamatzis, Alexandros Ardavanis,

Annals of Oncology

High-risk Stage IiOncologyGastrointestinal OncologyCancer ManagementAdjuvant ChemotherapyColorectal CancerOutcomes ResearchCancer TreatmentMedicineRadiation OncologyCancer ResearchInternational Duration Evaluation